Advanced search
Publication Cover
Infection and Drug Resistance Volume 14, 2021 - Issue
Submit an article Journal homepage
145
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Antibacterial Effects of Disulfiram in Helicobacter pylori

Tomomi Kobatake1 Graduate School of Health Science Okayama University, Okayama, 700-8558, Japan
,
Keiki Ogino2 Department of Environmental Medicine, Koch Medical School, Nankoku-shi, 783-8505, Japan
,
Hiroyuki Sakae3 Department of Gastroenterology and Hepatology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, 700-8558, Japan
,
Kazuyoshi Gotoh4 Department of Bacteriology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, 700-8558, Japan
,
Akari Watanabe5 Department of Oral Health Care and Rehabilitation, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, 770-8501, Japan
,
Osamu Matsushita4 Department of Bacteriology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, 700-8558, Japan
,
Hiroyuki Okada3 Department of Gastroenterology and Hepatology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, 700-8558, JapanORCID Iconhttps://orcid.org/0000-0003-2814-7146
ORCID Icon &
Kenji Yokota1 Graduate School of Health Science Okayama University, Okayama, 700-8558, JapanCorrespondence[email protected]
 show all
Pages 1757-1764 | Published online: 12 May 2021

References

  • IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:177–240.7715070
  • Blaser MJ. The bacteria behind ulcers. Sci Am. 1996;274(2):104–107. doi:10.1038/scientificamerican0296-1048560206
  • Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–789. doi:10.1056/NEJMoa00199911556297
  • Graham DY. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol. 2000;35:90–97.10779226
  • Lee YC, Chiang TH, Chou CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113–1124. doi:10.1053/j.gastro.2016.01.02826836587
  • Rokkas T, Rokka A, Portincasa P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann Gastroenterol. 2017;30(4):414–423. doi:10.20524/aog.2017.014428655977
  • Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization Regions. Gastroenterology. 2018;155(5):1372–1382. doi:10.1053/j.gastro.2018.07.00729990487
  • Franck J, Jayaram-Lindström N. Pharmacotherapy for alcohol dependence: status of current treatments. Curr Opin Neurobiol. 2013;23(4):692–699. doi:10.1016/j.conb.2013.05.00523810221
  • Skrott Z, Mistrik M, Andersen KK, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017;552(7684):194–199. doi:10.1038/nature2501629211715
  • Viola-Rhenals M, Patel KR, Jaimes-Santamaria L, Wu G, Liu J, Dou QP. Recent advances in antabuse (disulfiram): the importance of its metal-binding ability to its anticancer activity. Curr Med Chem. 2018;25(4):506–524. doi:10.2174/092986732466617102316112129065820
  • Sheppard JG, Frazier KR, Saralkar P, Hossain MF, Geldenhuys WJ, Long TE. Disulfiram-based disulfides as narrow-spectrum antibacterial agents. Bioorg Med Chem Lett. 2018;28(8):1298–1302. doi:10.1016/j.bmcl.2018.03.02329571571
  • Frazier KR, Moore JA, Long TE. Antibacterial activity of disulfiram and its metabolites. J Appl Microbiol. 2019;126(1):79–86. doi:10.1111/jam.1409430160334
  • Alba C, Blanco A, Alarcón T. Antibiotic resistance in Helicobacter pylori. Curr Opin Infect Dis. 2017;30(5):489–497. doi:10.1097/QCO.000000000000039628704226
  • Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7(11):629–641. doi:10.1038/nrgastro.2010.15420938460
  • Christensen JJ, Andresen K, Justesen T, Kemp M. Ribosomal DNA sequencing: experiences from use in the Danish National Reference Laboratory for Identification of Bacteria. APMIS. 2005;113(9):621–628. doi:10.1111/j.1600-0463.2005.apm_224.x16218938
  • Woo PCY, Lau SKP, Teng JLL, Tse H, Yuen K-Y. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect. 2008;14(10):908–934.18828852

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.